Financials
- Market Capitalization 13.54 B
- Employee 1 077
- Founded 1994
- CEO Michael M. Morrissey
- Website www.exelixis.com
- Headquarter Delaware, United States
- FIGI BBG000BQ4WF8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
17.41
売上高対価格比率
6.19
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 674 | ASND Ascendis Pharma A/S - American Depositary Shares | 263.04 USD | +6.10% | +3.96% | +7.50% | +28.26% | 16.30 B USD | ||
| 708 | BBIO BridgeBio Pharma, Inc. - Common Stock | 76.59 USD | -0.01% | -6.47% | -5.71% | +34.37% | 14.97 B USD | ||
| 791 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 65.23 USD | +0.87% | +0.31% | +7.94% | +11.70% | 12.63 B USD | ||
| 806 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 532.84 USD | -0.17% | +3.90% | +15.30% | +25.79% | 12.31 B USD |